Recent Articles

February 13, 2017 3:25 pm
Ryan Bushey
Another drug company reignited the debate over appropriate pricing policies for important medications.
February 13, 2017 10:28 am
Jeffrey Stein, Ph.D., President and CEO of Cidara Therapeutics, Chairman of Antimicrobials Working Group
The rise of drug-resistant “Superbugs” has been a public health concern for many years.
February 8, 2017 8:00 am
Jonathan Rennhack and Jing-Ru Jhan, Michigan State University, The Conversation
A better treatment strategy hinges upon understanding how heterogeneity within and between tumors arises.
February 8, 2017 3:00 pm
Arshad Ahad, Analyst, GBI Research
The commercial benefits Big Data can provide are incentivizing pharmaceutical and healthcare companies to embrace the technology.
February 8, 2017 3:51 pm
Ryan Bushey
More than 150 biotech CEOS, venture capitalists and startup founders signed a letter to the President expressing their deep concern and opposition to the order.
February 7, 2017 3:34 pm
Ryan Bushey
British-based GW Pharmaceuticals received more good news regarding its cannabis-based drug development efforts.
February 7, 2017 8:24 am
Richard Neubig, Michigan State University, The Conversation
The deadliest cancer of the skin is cutaneous melanoma.
February 6, 2017 8:33 am
Blaveen Kaur and Pravin Kaumaya, Ohio State University, The Conversation
The human immune system is powerful and complex.
February 6, 2017 9:38 am
Ryan Bushey
Investigators running this randomized, double-blind, placebo-controlled trial recruited 150 elderly patients diagnosed with acute myeloid leukemia.
February 3, 2017 3:42 pm
Northwestern University
The scientists determined that although there is some overlap in the pathways of Uba1 and Uba6, there are also downstream targets unique to each enzyme.
Subscribe to Drug Discovery & Development